Incor Pharma And Diagnostics Private Limited, a active private limited company, was established on 22 November 2012 in Serilingampally, Telangana, India. Engaging in hospitals within the hospital and medical care sector, it holds CIN: U85110TG2012PTC084319. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Shrihari Pulagam (Director), Gautham Reddy Madduri (Director). Past directors included Shrihari Pulagam, Suryanarayana Reddy Pulagam, Upendar Reddy Singatala. Its latest AGM occurred on 26 September 2025, with the balance sheet filed on 31 March 2025. It is based at Ground Floor, Vijetha Midas Touch Apartments, Sy No.6, White Field Road, Kondapur, Hyderabad, Serilingampally, Telangana, 500084.
U85110TG2012PTC084319
084319
22 November 2012
₹5.00 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Incor Pharma And Diagnostics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shrihari Pulagam | Director | 25 May 2022 | Current |
| Gautham Reddy Madduri | Director | 22 Nov 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 26 Sep 2022 | Past |
| Pramod Abcsdd | Director | 19 Nov 2018 | Past |
| Pramod Abcsdd | Director | 25 May 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Incor Pharma And Diagnostics Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 139.24% decrease in profit. The company's net worth dipped by a decrease of 1.68%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Incor Pharma And Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Incor Pharma And Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Incor Pharma And Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Incor Pharma And Diagnostics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Incor Pharma And Diagnostics Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records. was documented.
Progress on Incor Pharma And Diagnostics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.
Shrihari Pulagam was appointed as a Director was appointed as a Director on 25 May 2022 & has been associated with this company since 3 years 7 months . was recorded as a recent event.
Gautham Reddy Madduri was appointed as a Director was appointed as a Director on 22 Nov 2012 & has been associated with this company since 13 years 1 month . was recorded as a recent event.
Incor Pharma And Diagnostics Private Limited was registered on 22 Nov 2012 with Roc Hyderabad & aged 13 years 1 month as per MCA records. was recorded as a recent event.
The investment was made from Brookfield Asset Management's $4.5 billion global private equity fund.
The CIN of Incor Pharma And Diagnostics Private Limited is U85110TG2012PTC084319.
Incor Pharma And Diagnostics Private Limited is headquartered at Ground Floor, Vijetha Midas Touch Apartments, Sy No.6, White Field Road, Kondapur, Hyderabad, Serilingampally, Telangana, 500084.
Incor Pharma And Diagnostics Private Limited was incorporated on 22 November 2012.
The current directors of Incor Pharma And Diagnostics Private Limited are
The primary industry of Incor Pharma And Diagnostics Private Limited is Hospital And Medical Care.
Incor Pharma And Diagnostics Private Limited is unlisted.
The authorized capital of Incor Pharma And Diagnostics Private Limited is ₹5.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Incor Pharma And Diagnostics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX